Merck
Worldwide
   
En español

 



Be a Part of a Study

Thank you for your interest in this investigational study.

As new sites start enrolling, they will be added to the interactive map. You will see contact information on the map for each site.

You may also call Telerx for more information at 888-577-8839. Please reference study ID number 2005_097.

This study has been registered on www.ClinicalTrials.gov under identifiers: NCT00293254 (Brazil, Canada, Colombia, Mexico, Puerto Rico, USA)
NCT00293267 (Australia, Belgium, Denmark, France, Germany, Italy, Peru, Portugal, Spain, Switzerland, Taiwan, Thailand).

BENCHMRK
 
You may be eligible for the study if you are:
  • HIV positive with viral load greater than 1,000.
  • Have failed certain types of antiretroviral therapy.
  • On the same antiretroviral therapy for at least the past two months.
  • Are 16 years or older.
Participation in this 1-year study includes at no cost:
  • Regular doctor visits
  • Investigational study drug or placebo
  • Laboratory testing

Copyright © 2005-2007 Merck & Co., Inc., All rights reserved.

Contact Merck Privacy Policy Terms of Use Copyright Merck & CO., Inc. (USA)